Fair Value Measurements (Tables) - GREENLIGHT BIOSCIENCES HOLDINGS, PBC [Member]

3 Months Ended

Mar. 31, 2022

Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]

Schedule of assets and liabilities at fair value on a recurring basis

The following table presents information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values:

DESCRIPTION	MARCH 31, 2022		QUOTED PRICES IN ACTIVE MARKETS FOR IDENTICAL ASSETS (LEVEL 1)		SIGNIFICANT OBSERVABLE INPUTS (LEVEL 2)		SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3)
Asset
Money market funds		83,223		83,223		-		-
Total assets measured at fair value	$	83,223	$	83,223	$	—	$	—
Liability
Warrant liabilities		1,820		-		-		1,820
Total liabilities measured at fair value	$	1,820	$	—	$	—	$	1,820

DESCRIPTION	DECEMBER 31, 2021		QUOTED PRICES IN ACTIVE MARKETS FOR IDENTICAL ASSETS (LEVEL 1)		SIGNIFICANT OBSERVABLE INPUTS (LEVEL 2)		SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3)
Asset
Money market funds		31,446		31,446		-		-
Total assets measured at fair value	$	31,446	$	31,446	$	—	$	—
Liability
Warrant liabilities		2,105		-		-		2,105
Total liabilities measured at fair value	$	2,105	$	—	$	—	$	2,105

Schedule of changes in the fair value of Level 3 warrant liabilities

The following table presents a roll-forward of the aggregate fair values of the Company’s liabilities for which fair value is determined by Level 3 inputs:

	WARRANT LIABILITY
Balance—December 31, 2021	$	2,105
Warrants exercised in business combination		(1,633	)
Warrants reclassified to equity		(352	)
Change in fair value of warrants		359
Warrants assumed in business combination		1,341
Balance—March 31, 2022	$	1,820